Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM. - Wikidata - awgldk - TriplyDB

Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM.

Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM.

http://www.wikidata.org/entity/Q40379403

about

Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.Setting up low-risk bone marrow transplantation for children with thalassemia may facilitate pediatric cancer care.Outpatient care of patients with acute myeloid leukemia: Benefits, barriers, and future considerations Haploidentical Bone Marrow Transplantation in 2015 and Beyond.Patients' experiences of different care settings and a new life situation after allogeneic haematopoietic stem cell transplantation.A scoping review of caregiver burden during allogeneic HSCT: lessons learned and future directions.Family members' life situation and experiences of different caring organisations during allogeneic haematopoietic stem cells transplantation-A qualitative study.Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide in children and adolescents with hematological malignancies.Analysis of the feasibility of early hospital discharge after autologous hematopoietic stem cell transplantation and the implications to nursing care.General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care.Optimization of health-care organization and perceived improvement of patient comfort by switching from intra-venous BU four-times-daily infusions to a once-daily administration scheme in adult hematopoietic stem cell recipients.Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3-CD19 depletion.

P2860

Q36485407-82BE4434-B87D-40E9-B95E-2DA3A51A3298 Q37481685-EC1FC60A-2601-47A5-BD5C-667CADEE856B Q37740176-09D6DEBD-D08A-4381-AFBF-EA19F859C8E2 Q38607242-17DA1A44-BAAD-429A-9B7A-02016CE5557B Q38751585-156593E3-A3DF-47BB-8876-A27A4FB4903A Q38801133-B8D72618-427D-4C3A-AF03-C9BAF8B8F5F3 Q39176991-F494E338-5D65-4789-9DDF-EA103AB5E568 Q40660339-6B3A64F9-B560-4C1A-8575-4592326D3FBC Q42239300-0A5FF0DB-27E4-4A86-937E-005CD1B0AE26 Q43988469-AF6592F6-A08B-44CA-BF92-6B63452CAE3F Q48131864-0A0CCACE-3A54-4948-833E-075DB98F836D Q51817075-378A4EB3-D5EF-4237-9A77-5427549BC9A8

P2860

Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM.

http://www.wikidata.org/entity/Q40379403

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Outpatient myeloablative allo- ...... pital utilization and low TRM.

@en

type

label

Outpatient myeloablative allo- ...... pital utilization and low TRM.

@en

prefLabel

Outpatient myeloablative allo- ...... pital utilization and low TRM.

@en

P1433

Q40379403-D729D818-95E1-4EF6-9AD8-06D18A6EC5A4

P1476

Q40379403-C73EC011-4B7A-4E0E-8C78-D8D3C031D645

P2093

Q40379403-014E7C07-83A4-4E33-9A63-42D99214F154

Q40379403-117ECFB2-A679-460C-8D4D-90C76FE547E5

Q40379403-41727D73-DC9B-429E-BAA1-67A9776AFCF3

Q40379403-AC00D43C-B4C7-41F7-A68E-E3539CC3F125

Q40379403-B0B78EBE-C715-4DE4-A85D-ED6B9A3FA5D2

Q40379403-CF0A3D47-58FC-414D-9425-2E9D602A4253

Q40379403-D3A2846C-8CDF-4959-B225-A92DA2DCD1CA

Q40379403-DAF79549-51D8-42BA-A0A2-C95ECC9A3306

Q40379403-EFE8DA47-6EAA-4992-95BB-222DC25F4738

Q40379403-F25EFD60-F796-44DD-AF8C-B5441EC86236

P2860

Q40379403-0A40E296-C2E8-494D-A888-AD4FABB5A10F

Q40379403-218FB482-2754-4054-A180-2F75D66DB2E2

Q40379403-323C8B4C-309B-4C1C-82A6-BFD30E2A4E72

Q40379403-68AF04BB-7E1E-462F-BE3B-AB6BF998B307

Q40379403-7DF1C961-2142-4AE5-9972-7C356E308B8F

Q40379403-82F94C0A-4756-4C2E-B79F-97C45F8AED65

Q40379403-D6A1B60D-1383-4EAB-8C04-05B5C6AFBC43

Q40379403-D908AB5B-5993-418C-B193-DC780641D6D5

Q40379403-DEC9FD05-3597-49F5-BC00-6A14DC55A249

P2888

Q40379403-DAB64EA4-C154-4023-9245-EB189752FC2E

P304

Q40379403-CD4B1CBC-25BF-4EA9-B127-F726E9A06F53

P31

Q40379403-DC9E7C69-44F9-4B25-BD22-AB74CAD5C6D4

P356

Q40379403-B44C4675-7EBA-4D5A-84E1-6E50F34A4ABA

P407

Q40379403-2EC5F049-2333-475E-A41E-9320C7B0662B

P433

Q40379403-B1637FBB-8D40-4E87-B0EB-3A2FCF32857D

P478

Q40379403-2AC7FDAD-27CE-45F3-84A7-C8ADF2F24793

P577

Q40379403-AF9EED2A-DA89-480A-825C-896D003D9D02

P5875

Q40379403-F66E25E9-96B8-4651-ABEC-F042674A6BD5

P6179

Q40379403-EC8F8274-D7B2-4791-955A-769B623B9586

P698

Q40379403-539DD9EA-4D7C-4A57-8A58-1A17C0EC89E6

P356

P1433

Bone Marrow Transplantation

P1476

Outpatient myeloablative allo- ...... pital utilization and low TRM.

@en

P2093

A Bashey

http://www.w3.org/2001/XMLSchema#string

A M Barreras

http://www.w3.org/2001/XMLSchema#string

D G Connaghan

http://www.w3.org/2001/XMLSchema#string

D Speckhart

http://www.w3.org/2001/XMLSchema#string

H K Holland

http://www.w3.org/2001/XMLSchema#string

K L Manion

http://www.w3.org/2001/XMLSchema#string

K McNatt

http://www.w3.org/2001/XMLSchema#string

L E Morris

http://www.w3.org/2001/XMLSchema#string

R H Matthews

http://www.w3.org/2001/XMLSchema#string

S R Solomon

http://www.w3.org/2001/XMLSchema#string

P2860

Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer.

Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies.

Outpatient management of autologous haematopoietic cell transplantation: the Barcelona experience.

Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure.

Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: a 10-year experience.

Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.

Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.

Nonparametric Estimation from Incomplete Observations

Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia

P2888

P304

468-475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2009.234

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26825233

http://www.w3.org/2001/XMLSchema#string

P6179

1033213006

http://www.w3.org/2001/XMLSchema#string

P698

19767781

http://www.w3.org/2001/XMLSchema#string